CN Patent

CN103889429B — Sglt2抑制剂的结晶和非结晶形式

Assigned to Scinopharm Taiwan Ltd · Expires 2016-10-19 · 10y expired

What this patent protects

本发明提供SGLT2抑制剂的无定形形式和结晶复合物，用作新型物质，特别是药学上可接受的形式。SGLT2抑制剂卡纳格列净的晶型称为CS1型、CS2型、CS3型、CS4型和CS5型。

USPTO Abstract

本发明提供SGLT2抑制剂的无定形形式和结晶复合物，用作新型物质，特别是药学上可接受的形式。SGLT2抑制剂卡纳格列净的晶型称为CS1型、CS2型、CS3型、CS4型和CS5型。

Drugs covered by this patent

Patent Metadata

Patent number
CN103889429B
Jurisdiction
CN
Classification
—
Expires
2016-10-19
Drug substance claim
No
Drug product claim
No
Assignee
Scinopharm Taiwan Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.